Loeb & Loeb LLP | USA | 15 Mar 2024
In March 2024, an advisory firm settled charges with the U.S. Securities and Exchange Commission (SEC) that it failed to file a Schedule 13D…
Loeb & Loeb LLP | USA | 13 Mar 2024
Recent news reports have described the successful progress of at least one company, Varda Space Industries, in developing a space-based drug…
Loeb & Loeb LLP | USA | 12 Mar 2024
Only “natural persons” can be named “inventors” on U.S. patents. But last month, the U.S. Patent and Trademark Office (USPTO) issued guidance stating…
Loeb & Loeb LLP | USA | 11 Mar 2024
Last week, the New York Attorney General Letitia James filed a lawsuit against JBS USA Food Company, leading producer of beef products, alleging that…
Loeb & Loeb LLP | USA | 9 Mar 2024
The Biologics Price Competition and Innovation Act (“BPCIA”) created an abbreviated pathway for the licensure of biosimilar and interchangeable…
Loeb & Loeb LLP | USA | 8 Mar 2024
Late last month, the U.S. Securities and Exchange Commission (SEC) charged the CEO of a public company with making false and misleading statements on…
Loeb & Loeb LLP | USA | 8 Mar 2024
As 2024 heads into spring, the stage is set for a potentially pivotal ruling from the U.S. Supreme Court that will clarify the interplay between…